PEOPLE: changes in Novozymes' executive management:
Novozymes (Bagsvaerd, Denmark) is appointing two new executive vice-presidents, Dr Thomas Videbaek and Thomas Nagy. Dr Videbaek, who is currently vice-president of global enzyme sales, will become executive vice-president of biobusiness outside the enzyme area. Mr Nagy, site president of Novozymes North America, will be appointed executive vice-president of stakeholder relations. Dr Videbaek and Mr Nagy will take up their new posts on October 1st and, on the same date, Arne Schmidt, who is currently executive vice-president of development, production and quality, will retire after 37 years with Novo Nordisk and Novozymes.